Featured Click - Quiz: How are you feeling?

 

Learn how myfortic works

myfortic® delivers the same medicine as CellCept®, a common kidney antirejection treatment.
But myfortic is an enteric-coated formulation of mycophenolic acid (MPA) in a delayed-release tablet. That means that the coating on the tablet keeps it from dissolving in your stomach right after you take it. The active ingredient is not released until it reaches your small intestine. That's the myfortic difference.


Sign up for the myKidney Connection Program Today

The myKidney Connection Program is an ongoing source of tools, resources and
information on financial support to help you manage your post-transplant recovery.

Currently taking myfortic?
Start receiving myKidney Connection magazine, with articles and information for people taking myfortic.

Need kidney transplant info?
Visit the myKidney Connection web site and discover tools and resources for post-transplant.








Meet the newSTART Mentors

Meet the newSTART Mentors, real people like Scott who are taking myfortic. Hear their kidney transplant stories  >

 
 

Important Safety Information

 


 

myfortic Home | Before a Kidney Transplant | After a Kidney Transplant Treatment Options: myfortic and CellCept | Life With myfortic 
 More Transplant Resources| For Women Of Child Bearing Age
Prescribing Information | Important Safety Information | For Healthcare Professionals Glossary | Site Guide | Site Map | Contact Us
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2009
Novartis Pharmaceuticals Corporation. All rights reserved.